Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity was posted on August 9, 2016. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Evaluation of P16/K67 Dual Stained Slides as a Biomarker for Cervical Pre-cancer

Awarded
N02CP62651-57Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The National Cancer Institute's Division of Cancer Epidemiology and Genetics intends to award a sole source, firm fixed price contract to Ventana Medical Systems for the manual interpretation of approximately 20,000 SurePath cervical slide preparations. The project focuses on evaluating p16/ki67 dual stain cytology as a biomarker for cervical precancer to improve screening and triage strategies for HPV-positive women. The selected contractor is required to assess slide and staining quality, determine dual stain positivity, and provide a semi-quantitative estimate of positive cells, with all results delivered via Excel and slides returned to the NCI biorepository. The estimated period of performance is twelve months from the date of award. Ventana Medical Systems is identified as the sole source due to their role as the assay developer and their previous experience with the study population, ensuring data consistency. This procurement is processed under FAR Part 12 for commercial items using simplified acquisition procedures under NAICS code 541380. Interested parties must have valid certifications in the Central Contractor Registration and the Online Representations and Certifications Applications to be eligible for award.

General Info

Agency

N/A

Contract Value

$90,000

NAICS

541380 - Testing Laboratories and Services

Place of Performance

Contractor's site, MD, USA

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded
Posted

Presolicitation

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Reyes RodriguezContracting Officer

Full Description

Show more
National Cancer Institute (NCI), Division of Cancer Epidemiology and Genetics (DCEG), plans to procure on a sole source basis services to conduct manual interpretation of approximately 20,000 SurePath cervical slide preparations stained with the CINtec PLUS dual stain cytology kit from women enrolled in a study on cervical cancer screening and triage and return slides to the NCI biorepository from Ventana Medical Systems 1910 East Innovation Park Drive Tucson AZ 85755 USA. This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.106-1(b)(1), using simplified acquisition procedures for commercial acquisitions. The North American Industry Classification System code is 541380 and the business size standard is $14.0 Million. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. The period of performance is estimated to be twelve (12) months from date of award. It has been determined there are no opportunities to acquire green products or services for this procurement. HPV testing alone or with cytology ("cotesting") is being introduced into primary screening. The multiplicity of new options creates confusion over how to best incorporate HPV testing. Because most HPV infections are harmless, additional triage tests must identify HPV-positive women at highest cancer risk and no best strategy has been identified. Cytologic staining for p16/ki67 is a promising assay to identify cervical precancers. The cellular protein p16 is upregulated in transforming HPV infections and serves as an HPV-type independent biomarker of cervical precancer. p16 immunostaining protocols have been developed for cervical cytology. The dual stain slides need to be evaluated by an experienced cytotechnologist, detection of a single dual stain positive cell on the slide is considered a positive result. NCI is conducting a larger study evaluating different biomarkers for cervical cancer screening. As part of this study, a large series of dual stain positive slides are created that need to be read by a cytotechnologist experienced with the dual stain cytology. Contractor Requirements The contractor shall perform the following tasks: 1. Read 20,000 cytology slides. For each slide, the reader shall document: - Slide and staining quality (sufficient, insufficient, and reasons for insufficiency) - Dual stain positivity (yes, no) - Estimated number of dual stain positive cells (semi-quantitative) 2. Send all results to NCI in an Excel spreadsheet 3. At the end of the contract, stained slides shall be shipped to the NCI repository at room temperature. The NCI and Division of Cancer Epidemiology and Genetics has conducted previous studies from the same population in which dual stained slides were read by the proposed contractor. The contractor is the developer of the assay and has the greatest experience with reading dual stain cytology. To achieve the proposed goals, it is important to have consistent evaluation of dual stained cells that allow pooling the existing data with the current study. Thus, Ventana Medical Systems is the only known source that can provide a p16/ki67 staining and reading service to meet the Government's needs at this time. This notice is not a request for competitive quotation. However, if any interested party, especially small business believes it can meet the above requirement, it may submit a proposal or quote for the Government to consider. The response and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. Responses must be received in the contracting office by 4 PM EST, on August 18, 2016. All responses and questions must be in writing and faxed +1 (555) 000-0000 or emailed to Reyes Rodriguez, Contracting Officer via electronic mail at contact@example.gov. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. In order to receive an award, contractors must be registered and have valid certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA) through sam.gov. Reference: N02CP62651-57 on all correspondence.

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS